Author Index Volume 52 (2016)
The issue number is given in front of the pagination
Aalten, P., see Handels, R.L.H. (3) 875–885
Abe, K., see Shang, J. (1) 113–126
Abe, K., see Takemoto, M. (1) 205–211
Abe, K., see Zhai, Y. (4) 1311–1319
Acevedo, B., see Eyre, H.A. (2) 673–684
Acosta, L.M.Y., see Jefferson, A.L. (2) 539–559
Adame, A., see Waragai, M. (4) 1453–1459
Agostinho, P., see Pliássova, A. (4) 1209–1214
Aguilar-Vázquez, A.R., see Ontiveros-Torres, M.Á. (1) 243–269
Ahmed, S., I. Baker, M. Husain, S. Thompson, C. Kipps, M. Hornberger, J.R. Hodges and C.R. Butler, Memory Impairment at Initial Clinical Presentation in Posterior Cortical Atrophy (4) 1245–1250
Ahonen, H., see Clements-Cortes, A. (2) 651–660
Alafuzoff, I., see Koivisto, A.M. (2) 497–507
Albani, D., see Clarelli, F. (4) 1203–1208
Aleman, I.T., see Fernandez, A.M. (4) 1471–1478
Alexander-Bloch, A.F., see Zhan, Y. (3) 913–927
Allison, S.L., A.M. Fagan, J.C. Morris and D. Head, Spatial Navigation in Preclinical Alzheimer’s Disease (1) 77–90
Allouche, A., see Colin, J. (3) 975–987
Ames, D., see Connors, M.H. (3) 967–974
An, S.S.A., see Wang, M.J. (4) 1403–1413
Andreasen, N., see Lelental, N. (1) 51–64
Andreasson, U., see Lelental, N. (1) 51–64
Annapragada, A., see Tanifum, E.A. (2) 731–745
Annemans, L., see Vandepitte, S. (3) 929–965
Antoine, P., see El Haj, M. (2) 421–431
Arancio, O., see Teich, A.F. (1) 295–302
Arena, A., see Tramutola, A. (1) 359–371
Ashton, N.J., see Westwood, S. (2) 561–572
Assareh, A.A., see Heffernan, M. (2) 529–538
Asthana, S., see Hoscheidt, S.M. (4) 1373–1383
Atarashi, H., see Homma, A. (1) 345–357
Atwood, C.S., see Hoscheidt, S.M. (4) 1373–1383
Austin, D., see Silbert, L.C. (2) 713–717
Ávila, J., see Torres-Cruz, F.M. (2) 463–482
Ávila-Villanueva, M., see Fernández-Blázquez, M.A. (1) 271–281
Ayres, A.M., see Xiong, L. (1) 171–178
Ayuso, C., see Gómez-Tortosa, E. (1) 25–31
Bagyinszky, E., see Wang, M.J. (4) 1403–1413
Bahl, J.M.C., see Lelental, N. (1) 51–64
Bai, F., see Ye, Q. (1) 1–15
Baird, A.L., see Westwood, S. (2) 561–572
Baker, D., see Westwood, S. (2) 561–572
Baker, I., see Ahmed, S. (4) 1245–1250
Baldeiras, I., see Lelental, N. (1) 51–64
Balmaceda, V., see Cuchillo-Ibañez, I. (2) 403–416
Bangen, K.J., A.L. Clark, M. Werhane, E.C. Edmonds, D.A. Nation, N. Evangelista, D.J. Libon, M.W. Bondi and L. Delano-Wood for the Alzheimer’s Disease Neuroimaging Initiative, Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive Impairment Subtypes and Interaction with APOE ɛ4 Genotype (3) 849–861
Bankiewicz, K., see Spilman, P.R. (1) 223–242
Barabash, A., see López, M.E. (1) 133–143
Barone, E., see Tramutola, A. (1) 359–371
Barragán-Andrade, N., see Torres-Cruz, F.M. (2) 463–482
Barry, H.E., J.A. Cooper, C. Ryan, A.P. Passmore, A.L. Robinson, G.J. Molloy, C.M. Darcy, H. Buchanan and C.M. Hughes, Potentially Inappropriate Prescribing Among People with Dementia in Primary Care: A Retrospective Cross-Sectional Study Using the Enhanced Prescribing Database (4) 1503–1513
Bartel, L., see Clements-Cortes, A. (2) 651–660
Baschieri, F., see Müller, M. (4) 1321–1333
Basurto-Islas, G., see Torres-Cruz, F.M. (2) 463–482
Bates, K.A., see Gardener, S.L. (2) 661–672
Baune, B.T., see Eyre, H.A. (2) 673–684
Bazenet, C., see Westwood, S. (2) 561–572
Beach, T.G., D.R. Thal, M. Zanette, A. Smith and C. Buckley, Detection of Striatal Amyloid Plaques with [18F]flutemetamol: Validation with Postmortem Histopathology (3) 863–873
Beauchemin, É., see Bier, N. (4) 1361–1371
Beauregard, J.-M., see Bensaïdane, M.R. (4) 1251–1262
Becker, J.T., see Raji, C.A. (2) 719–729
Beheshti, I., H.G.T. Olya, H. Demirel and for the Alzheimer’s Disease Neuroimaging Initiative, Risk Assessment of Alzheimer’s Disease using the Information Diffusion Model from Structural Magnetic Resonance Imaging (4) 1335–1342
Behrens, S., see Sanders, C. (1) 33–42
Bell, S.P., see Jefferson, A.L. (2) 539–559
Bendlin, B.B., see Hoscheidt, S.M. (4) 1373–1383
Bennett, E.R., see Berger, M. (4) 1299–1310
Bensaïdane, M.R., J.-M. Beauregard, S. Poulin, F.-A. Buteau, J. Guimond, D. Bergeron, L. Verret, M.-P. Fortin, M. Houde, R.W. Bouchard, J.-P. Soucy and R. Jr Laforce, Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers (4) 1251–1262
Benzinger, T.L.S., see Ingber, A.P. (3) 1055–1064
Berendt, M., see Schütt, T. (2) 433–449
Berg, D., see Roeben, B. (1) 161–169
Berger, M., J.W. Nadler, A. Friedman, D.L. McDonagh, E.R. Bennett, M. Cooter, W. Qi, D.T. Laskowitz, V. Ponnusamy, M.F. Newman, L.M. Shaw, D.S. Warner, J.P. Mathew and M.L. James for the MAD-PIA investigators, The Effect of Propofol Versus Isoflurane Anesthesia on Human Cerebrospinal Fluid Markers of Alzheimer’s Disease: Results of a Randomized Trial (4) 1299–1310
Bergeron, D., see Bensaïdane, M.R. (4) 1251–1262
Berres, M., see Hirni, D.I. (2) 573–580
Betsou, F., see Lelental, N. (1) 51–64
Beydoun, H.A., see Beydoun, M.A. (4) 1415–1430
Beydoun, M.A., J.-A. Canas, G.A. Dore, H.A. Beydoun, O.S. Rostant, M.T. Fanelli-Kuczmarski, M.K. Evans and A.B. Zonderman, Serum Uric Acid and Its Association with Longitudinal Cognitive Change Among Urban Adults (4) 1415–1430
Beyer, J., see Spilman, P.R. (1) 223–242
Bier, N., P. da Cunha Belchior, G. Paquette, É. Beauchemin, A. Lacasse-Champagne, C. Messier, M.-L. Pellerin, M. Petit, E. Mioshi and C. Bottari, The Instrumental Activity of Daily Living Profile in Aging: A Feasibility Study (4) 1361–1371
Blacker, D.L., see Xiong, L. (1) 171–178
Blanc, F., see Cretin, B. (3) 1125–1133
Blarzino, C., see Tramutola, A. (1) 359–371
Blennow, K., see Hoscheidt, S.M. (4) 1373–1383
Blennow, K., see Lelental, N. (1) 51–64
Bondi, M.W., see Bangen, K.J. (3) 849–861
Bondi, M.W., see Edmonds, E.C. (2) 685–691
Boneschi, F.M., see Clarelli, F. (4) 1203–1208
Borroni, B., see Premi, E. (4) 1227–1235
Bottari, C., see Bier, N. (4) 1361–1371
Bouchard, R.W., see Bensaïdane, M.R. (4) 1251–1262
Boundy, K., see Connors, M.H. (3) 967–974
Bousiges, O., see Cretin, B. (3) 1125–1133
Bouwman, F., see Handels, R.L.H. (3) 875–885
Brandner, S., see Lelental, N. (1) 51–64
Bredesen, D.E., see Spilman, P.R. (1) 223–242
Brickman, A.M., see Zahodne, L.B. (3) 1013–1020
Brockmann, K., see Roeben, B. (1) 161–169
Brodaty, H., see Connors, M.H. (3) 967–974
Brodaty, H., see Heffernan, M. (2) 529–538
Broekaart, D., see Tramutola, A. (1) 359–371
Brosseron, F., see Lelental, N. (1) 51–64
Brugghe, H.F., see Mulder, C.K. (3) 1111–1123
Bruña, R., see López, M.E. (1) 133–143
Brunel, N., see Vidal, J.-S. (2) 641–649
Bu, X.-L., see Liu, C.-H. (3) 1081–1088
Buchanan, H., see Barry, H.E. (4) 1503–1513
Buchfelder, M., see Lelental, N. (1) 51–64
Buckley, C., see Beach, T.G. (3) 863–873
Buschke, H., see Gramunt, N. (1) 283–293
Buteau, F.-A., see Bensaïdane, M.R. (4) 1251–1262
Butler, C.R., see Ahmed, S. (4) 1245–1250
Butterfield, D.A., see Tramutola, A. (1) 359–371
Butters, M.A., see Lingler, J.H. (1) 17–24
Butz, M., see Matura, S. (1) 317–331
Buxbaum, J.N., see Li, X. (4) 1263–1275
Cabranes, J.A., see López, M.E. (1) 133–143
Cai, X., see Zhang, X. (1) 101–111
Callahan, B.L., M. Simard, A. Mouiha, F. Rousseau, R. Jr. Laforce and C. Hudon, Impact of Depressive Symptoms on Memory for Emotional Words in Mild Cognitive Impairment and Late-Life Depression (2) 451–462
Campagna, J., see Spilman, P.R. (1) 223–242
Canas, J.-A., see Beydoun, M.A. (4) 1415–1430
Canas, P.M., see Pliássova, A. (4) 1209–1214
Cao, L., see Wang, H.-F. (1) 179–190
Cao, Q., see Zeng, L. (3) 813–823
Cao, Y., see Zeng, L. (3) 813–823
Carlsson, C.M., see Hoscheidt, S.M. (4) 1373–1383
Carmichael, O.T., see Raji, C.A. (2) 719–729
Cereda, C., see Westwood, S. (2) 561–572
Cestari, J.A.F., G.M.C. Fabri, J. Kalil, R. Nitrini, W. Jacob-Filho, J.T.T. de Siqueira and S.R.D.T. Siqueira, Oral Infections and Cytokine Levels in Patients with Alzheimer’s Disease and Mild Cognitive Impairment Compared with Controls (4) 1479–1485
Chan, Q.L., see Xu, X. (3) 1021–1028
Charidimou, A., see Xiong, L. (1) 171–178
Chauveau, F., see Colin, J. (3) 975–987
Chen, C.L.-H., see Xu, X. (3) 1021–1028
Chen, Y., see Zeng, L. (3) 813–823
Chen, Y.-F., see Henneges, C. (3) 1065–1080
Cheng, C.-Y., see Xu, X. (3) 1021–1028
Cheng, S., see Zeng, L. (3) 813–823
Chiasserini, D., see Lelental, N. (1) 51–64
Chiasserini, D., see Müller, M. (4) 1321–1333
Choe, B.-Y., see Jahng, G.-H. (1) 145–159
Choi, S.H., see Yoon, B. (1) 91–99
Chun, I.K., see Wang, M.J. (4) 1403–1413
Claassen, J., see Handels, R.L.H. (3) 875–885
Claassen, J.A., see Müller, M. (4) 1321–1333
Clarelli, F., E. Mascia, R. Santangelo, S. Mazzeo, G. Giacalone, D. Galimberti, F. Fusco, M. Zuffi, C. Fenoglio, M. Franceschi, E. Scarpini, G. Forloni, G. Magnani, G. Comi, D. Albani and F.M. Boneschi, CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer’s Disease Patients (4) 1203–1208
Clark, A.L., see Bangen, K.J. (3) 849–861
Clarnette, R., see Connors, M.H. (3) 967–974
Claudepierre, T., see Colin, J. (3) 975–987
Clements-Cortes, A., H. Ahonen, M. Evans, M. Freedman and L. Bartel, Short-Term Effects of Rhythmic Sensory Stimulation in Alzheimer’s Disease: An Exploratory Pilot Study (2) 651–660
Colin, J., A. Allouche, F. Chauveau, C. Corbier, L. Pauron-Gregory, M.-C. Lanhers, T. Claudepierre, F.T. Yen, T. Oster and C. Malaplate-Armand, Improved Neuroprotection Provided by Drug Combination in Neurons Exposed to Cell-Derived Soluble Amyloid-β Peptide (3) 975–987
Collinson, S.L., see Xu, X. (3) 1021–1028
Comi, G., see Clarelli, F. (4) 1203–1208
Conde-Sala, J.L., O. Turró-Garriga, C. Portellano-Ortiz, V. Viñas-Diez, J. Gascón-Bayarri and R. Reñé-Ramírez, Self-Perceived Quality of Life Among Patients with Alzheimer’s Disease: Two Longitudinal Models of Analysis (3) 999–1012
Connors, M.H., D. Ames, K. Boundy, R. Clarnette, S. Kurrle, A. Mander, J. Ward, M. Woodward and H. Brodaty, Predictors of Mortality in Dementia: The PRIME Study (3) 967–974
Cooper, J.A., see Barry, H.E. (4) 1503–1513
Cooter, M., see Berger, M. (4) 1299–1310
Corbier, C., see Colin, J. (3) 975–987
Corcoran, C.D., see Sanders, C. (1) 33–42
Correia, M., see Lopes, J. (3) 801–812
Corset, V., see Spilman, P.R. (1) 223–242
Cosseddu, M., see Premi, E. (4) 1227–1235
Costa, P., see Premi, E. (4) 1227–1235
Cretin, B., F. Sellal, N. Philippi, O. Bousiges, L. Di Bitonto, C. Martin-Hunyadi and F. Blanc, Epileptic Prodromal Alzheimer’s Disease, a Retrospective Study of 13 New Cases: Expanding the Spectrum of Alzheimer’s Disease to an Epileptic Variant? (3) 1125–1133
Cuchillo-Ibañez, I., V. Balmaceda, T. Mata-Balaguer, I. Lopez-Font and J. Sáez-Valero, Reelin in Alzheimer’s Disease, Increased Levels but Impaired Signaling: When More is Less (2) 403–416
Cuesta, P., see López, M.E. (1) 133–143
Cui, Y., see Zhan, Y. (3) 913–927
Cunha, R.A., see Pliássova, A. (4) 1209–1214
Cyr, N. St., see Eyre, H.A. (2) 673–684
da Cruz e Silva, O., see Lopes, J. (3) 801–812
da Cunha Belchior, P., see Bier, N. (4) 1361–1371
da Silva, B.S., see Pliássova, A. (4) 1209–1214
Damian, M., see Jekel, K. (2) 509–517
Darcy, C.M., see Barry, H.E. (4) 1503–1513
Davidsdottir, S., see Xiong, L. (1) 171–178
Davis, L.T., see Jefferson, A.L. (2) 539–559
de Labra, C., see Sánchez, A. (1) 303–315
de Leon, M., see Kim, H.-J. (3) 1101–1109
De Roeck, N., see Müller, M. (4) 1321–1333
de Siqueira, J.T.T., see Cestari, J.A.F. (4) 1479–1485
Delano-Wood, L., see Bangen, K.J. (3) 849–861
Delano-Wood, L., see Edmonds, E.C. (2) 685–691
Delgadillo, I., see Lopes, J. (3) 801–812
Dell’Agnello, G., see Henneges, C. (3) 1065–1080
Demirel, H., see Beheshti, I. (4) 1335–1342
Deng, B., see Liu, C.-H. (3) 1081–1088
Deshpande, A., see Kim, H.-J. (3) 1101–1109
Di Bitonto, L., see Cretin, B. (3) 1125–1133
Di Domenico, F., see Tramutola, A. (1) 359–371
Díaz, F., see Ramos-Goicoa, M. (4) 1487–1501
Díaz-Cintra, S., see Ontiveros-Torres, M.Á. (1) 243–269
Diéguez-Vide, F., see Gramunt, N. (1) 283–293
Dodge, H.H., see Silbert, L.C. (2) 713–717
Domide, L., see Iyappan, A. (4) 1343–1360
Dominguez-Fraile, M., see Fernandez, A.M. (4) 1471–1478
Donahue, M.J., see Jefferson, A.L. (2) 539–559
Dong, Y., see Mulder, C.K. (3) 1111–1123
Dore, G.A., see Beydoun, M.A. (4) 1415–1430
Downer, B., S.P. Veeranki and R. Wong, A Late Life Risk Index for Severe Cognitive Impairment in Mexico (1) 191–203
Draper, B., see Heffernan, M. (2) 529–538
Dreier, A., see Eichler, T. (2) 619–629
Dreier, A., see Thyrian, J.R. (2) 609–617
Dubois, B., see Lelental, N. (1) 51–64
Duron, E., see Vidal, J.-S. (2) 641–649
Dvorak-Ewell, M., see Spilman, P.R. (1) 223–242
Dyk, K.V., see Eyre, H.A. (2) 673–684
Ebrahimie, E., S.H.M. Nik, M. Newman, M.V.D. Hoek and M. Lardelli, The Zebrafish Equivalent of Alzheimer’s Disease-Associated PRESENILIN Isoform PS2V Regulates Inflammatory and Other Responses to Hypoxic Stress (2) 581–608
Edmonds, E.C., L. Delano-Wood, A.J. Jak, D.R. Galasko, D.P. Salmon and M.W. Bondi for the Alzheimer’s Disease Neuroimaging Initiative, “Missed” Mild Cognitive Impairment: High False-Negative Error Rate Based on Conventional Diagnostic Criteria (2) 685–691
Edmonds, E.C., see Bangen, K.J. (3) 849–861
Eichler, T., see Thyrian, J.R. (2) 609–617
Eichler, T., W. Hoffmann, J. Hertel, S. Richter, D. Wucherer, B. Michalowsky, A. Dreier and J.R. Thyrian, Living Alone with Dementia: Prevalence, Correlates and the Utilization of Health and Nursing Care Services (2) 619–629
Eisel, U.L.M., see Mulder, C.K. (3) 1111–1123
El Haj, M., D. Kapogiannis and P. Antoine, Phenomenological Reliving and Visual Imagery During Autobiographical Recall in Alzheimer’s Disease (2) 421–431
Elmståhl, S., see Nilsson, E.D. (3) 1047–1053
Engelborghs, S., see Lelental, N. (1) 51–64
Engelborghs, S., see Müller, M. (4) 1321–1333
Epelbaum, J., see Vidal, J.-S. (2) 641–649
Ercoli, L., see Eyre, H.A. (2) 673–684
Erickson, K.I., see Raji, C.A. (2) 719–729
Eriksen, J.L., see Tanifum, E.A. (2) 731–745
Erten-Lyons, D., see Silbert, L.C. (2) 713–717
Eschweiler, G.W., see Roeben, B. (1) 161–169
Escobar-Herrera, J., see Torres-Cruz, F.M. (2) 463–482
Evangelista, N., see Bangen, K.J. (3) 849–861
Evans, M., see Clements-Cortes, A. (2) 651–660
Evans, M.K., see Beydoun, M.A. (4) 1415–1430
Eyre, H., see Raji, C.A. (2) 719–729
Eyre, H.A., B. Acevedo, H. Yang, P. Siddarth, K.V. Dyk, L. Ercoli, A.M. Leaver, N. St. Cyr, K. Narr, B.T. Baune, D.S. Khalsa and H. Lavretsky, Changes in Neural Connectivity and Memory Following a Yoga Intervention for Older Adults: A Pilot Study (2) 673–684
Fabri, G.M.C., see Cestari, J.A.F. (4) 1479–1485
Faes, K., see Vandepitte, S. (3) 929–965
Fagan, A.M., see Allison, S.L. (1) 77–90
Fagan, A.M., see Ingber, A.P. (3) 1055–1064
Fanelli-Kuczmarski, M.T., see Beydoun, M.A. (4) 1415–1430
Fang, Y., see Zhang, X. (1) 101–111
Farotti, L., see Müller, M. (4) 1321–1333
Fastbom, J., see Pimouguet, C. (1) 213–222
Fauria, K., see Gramunt, N. (1) 283–293
Feng, Q., see Zhan, Y. (3) 913–927
Fenoglio, C., see Clarelli, F. (4) 1203–1208
Ferini-Strambi, L., see Iaccarino, L. (3) 989–997
Fernández, A., see López, M.E. (1) 133–143
Fernandez, A.M., R. Hervas, M. Dominguez-Fraile, V.N. Garrido, P. Gomez-Gutierrez, M. Vega, J. Vitorica, J.J. Perez and I.T. Aleman, Blockade of the Interaction of Calcineurin with FOXO in Astrocytes Protects Against Amyloid-β-Induced Neuronal Death (4) 1471–1478
Fernández-Blázquez, M.A., M. Ávila-Villanueva, F. Maestú and M. Medina, Specific Features of Subjective Cognitive Decline Predict Faster Conversion to Mild Cognitive Impairment (1) 271–281
Fiorito, J., see Teich, A.F. (1) 295–302
Florán-Garduño, B., see Ontiveros-Torres, M.Á. (1) 243–269
Flores-Rodríguez, P., see Ontiveros-Torres, M.Á. (1) 243–269
Fluck, J., see Iyappan, A. (4) 1343–1360
Forloni, G., see Clarelli, F. (4) 1203–1208
Fortin, M.-P., see Bensaïdane, M.R. (4) 1251–1262
Foster, J.K., see Gardener, S.L. (2) 661–672
Fotiadis, P., see Xiong, L. (1) 171–178
Franceschi, M., see Clarelli, F. (4) 1203–1208
Franco-Macías, E., see Gómez-Tortosa, E. (1) 25–31
Fratiglioni, L., see Pimouguet, C. (1) 213–222
Freedman, M., see Clements-Cortes, A. (2) 651–660
Friedman, A., see Berger, M. (4) 1299–1310
Frölich, L., see Jekel, K. (2) 509–517
Frölich, L., see Lelental, N. (1) 51–64
Fukui, Y., see Shang, J. (1) 113–126
Fukui, Y., see Zhai, Y. (4) 1311–1319
Fukuyama, H., see Ota, K. (4) 1385–1401
Funalot, B., see Vidal, J.-S. (2) 641–649
Fusco, F., see Clarelli, F. (4) 1203–1208
Fußer, F., see Matura, S. (1) 317–331
Gabryelewicz, T., see Lelental, N. (1) 51–64
Gach, H.M., see Raji, C.A. (2) 719–729
Gaenslen, A., see Roeben, B. (1) 161–169
Galasko, D.R., see Edmonds, E.C. (2) 685–691
Galdo-Álvarez, S., see Ramos-Goicoa, M. (4) 1487–1501
Galimberti, D., see Clarelli, F. (4) 1203–1208
Gallego, J., see Gómez-Tortosa, E. (1) 25–31
Galvan, V., see Spilman, P.R. (1) 223–242
Garcia-Sierra, F., see Torres-Cruz, F.M. (2) 463–482
Gardener, S.L., H.R. Sohrabi, K.-k. Shen, S.R. Rainey-Smith, M. Weinborn, K.A. Bates, T. Shah, J.K. Foster, N. Lenzo, O. Salvado, C. Laske, S.M. Laws, K. Taddei, G. Verdile and R.N. Martins, Cerebral Glucose Metabolism is Associated with Verbal but not Visual Memory Performance in Community-Dwelling Older Adults (2) 661–672
Garrido, V.N., see Fernandez, A.M. (4) 1471–1478
Gascón-Bayarri, J., see Conde-Sala, J.L. (3) 999–1012
Gasparotti, R., see Premi, E. (4) 1227–1235
Gawryluk, J.R., see Smart, C.M. (2) 757–774
Gentry, A.L., see Lingler, J.H. (1) 17–24
Ghaghada, K., see Tanifum, E.A. (2) 731–745
Giacalone, G., see Clarelli, F. (4) 1203–1208
Giau, V.V., see Wang, M.J. (4) 1403–1413
Gifford, K.A., see Jefferson, A.L. (2) 539–559
Gil, P., see López, M.E. (1) 133–143
Gispert, J.D., see Gramunt, N. (1) 283–293
Gkatzima, O., see Lelental, N. (1) 51–64
Gleason, C.E., see Hoscheidt, S.M. (4) 1373–1383
Godau, J., see Roeben, B. (1) 161–169
Gomez-Gutierrez, P., see Fernandez, A.M. (4) 1471–1478
Gómez-Tortosa, E., C. Prieto-Jurczynska, S. Serrano, E. Franco-Macías, L. Olivié, J. Gallego, R. Guerrero-López, M.J. Trujillo-Tiebas, C. Ayuso, P.G. Ruiz, J. Pérez-Pérez and M.J. Sainz, Diversity of Cognitive Phenotypes Associated with C9ORF72 Hexanucleotide Expansion (1) 25–31
Gorostiza, O., see Spilman, P.R. (1) 223–242
Gottlieb, J.A., see Jefferson, A.L. (2) 539–559
Graf, J., see Westwood, S. (2) 561–572
Gramunt, N., G. Sánchez-Benavides, H. Buschke, F. Diéguez-Vide, J. Peña-Casanova, X. Masramon, K. Fauria, J.D. Gispert and J.L. Molinuevo, The Memory Binding Test: Development of Two Alternate Forms into Spanish and Catalan (1) 283–293
Grant, E.A., see Ingber, A.P. (3) 1055–1064
Greenberg, S.M., see Xiong, L. (1) 171–178
Grodstein, F., see Vercambre, M.-N. (3) 887–898
Grothe, M.J., see Teipel, S. (4) 1443–1451
Grüner, E., see Roeben, B. (1) 161–169
Gualeni, V., see Premi, E. (4) 1227–1235
Guerrero-López, R., see Gómez-Tortosa, E. (1) 25–31
Guimond, J., see Bensaïdane, M.R. (4) 1251–1262
Gulisano, W., see Palmeri, A. (1) 65–75
Gündel, M., see Iyappan, A. (4) 1343–1360
Guo, J., see Zhang, X. (1) 101–111
Guo, Y., see Huang, H.-C. (3) 899–911
Gupta, D.K., see Jefferson, A.L. (2) 539–559
Gurol, E., see Xiong, L. (1) 171–178
Ham, J.H., see Ye, B.S. (4) 1237–1243
Han, J.-y., see Kim, H.-J. (3) 1101–1109
Han, J.-y., see Wang, M.J. (4) 1403–1413
Han, P. and J. Shi, A Theoretical Analysis of the Synergy of Amyloid and Tau in Alzheimer’s Disease (4) 1461–1470
Handels, R.L.H., M.A. Joore, S.J.B. Vos, P. Aalten, I.H.G.B. Ramakers, M.O. Rikkert, P. Scheltens, W.J. Jansen, P.-J. Visser, B.M.N. van Berckel, P. van Domburg, M. Smid, E. Hoff, J. Hoogmoed, F. Bouwman, J. Claassen, A.F.G. Leentjens, C.A.G. Wolfs, J.L. Severens and F.R.J. Verhey, Added Prognostic Value of Cerebrospinal Fluid Biomarkers in Predicting Decline in Memory Clinic Patients in a Prospective Cohort (3) 875–885
Hanon, O., see Vidal, J.-S. (2) 641–649
Hao, F., see Hu, Q. (2) 747–756
Hao, X.-K., see Wang, H.-F. (1) 179–190
Hao, X.-K., see Zhao, Q.-F. (2) 693–703
Hartikainen, S., see Tiihonen, M. (1) 127–132
Hartmann, D., see Matura, S. (1) 317–331
Hashimoto, M., see Sekiyama, K. (3) 831–841
Hashimoto, M., see Waragai, M. (4) 1453–1459
Hassenstab, J., see Ingber, A.P. (3) 1055–1064
Hatanaka, N., see Takemoto, M. (1) 205–211
Hattingen, E., see Matura, S. (1) 317–331
Hattori, Y., T. Maki, S. Saito, Y. Yamamoto, K. Nagatsuka and M. Ihara, Influence of Low-Dose Aspirin on Cerebral Amyloid Angiopathy in Mice (3) 1037–1045
Hausner, L., see Jekel, K. (2) 509–517
Hausner, L., see Lelental, N. (1) 51–64
Head, D., see Allison, S.L. (1) 77–90
Head, E., see Tanifum, E.A. (2) 731–745
Head, E., see Tramutola, A. (1) 359–371
Heffernan, M., K.A. Mather, J. Xu, A.A. Assareh, N.A. Kochan, S. Reppermund, B. Draper, J.N. Trollor, P. Sachdev and H. Brodaty, Alcohol Consumption and Incident Dementia: Evidence from the Sydney Memory and Ageing Study (2) 529–538
Hehir, C.T., see Westwood, S. (2) 561–572
Heinzel, S., see Roeben, B. (1) 161–169
Helboe, L., see Schütt, T. (2) 433–449
Henneges, C., C. Reed, Y.-F. Chen, G. Dell’Agnello and J. Lebrec, Describing the Sequence of Cognitive Decline in Alzheimer’s Disease Patients: Results from an Observational Study (3) 1065–1080
Henriques, A.G., see Lopes, J. (3) 801–812
Hertel, J., see Eichler, T. (2) 619–629
Hertel, J., see Thyrian, J.R. (2) 609–617
Herukka, S.-K., see Lelental, N. (1) 51–64
Hervas, R., see Fernandez, A.M. (4) 1471–1478
Hilal, S., see Xu, X. (3) 1021–1028
Hirni, D.I., S.L. Kivisaari, S. Krumm, A.U. Monsch, M. Berres, F. Oeksuez, J. Reinhardt, S. Ulmer, R.W. Kressig, C. Stippich and K.I. Taylor, Neuropsychological Markers of Medial Perirhinal and Entorhinal Cortex Functioning are Impaired Twelve Years Preceding Diagnosis of Alzheimer’s Dementia (2) 573–580
Hishikawa, N., see Shang, J. (1) 113–126
Hishikawa, N., see Takemoto, M. (1) 205–211
Hishikawa, N., see Zhai, Y. (4) 1311–1319
Hodges, J.R., see Ahmed, S. (4) 1245–1250
Hoek, M.V.D., see Ebrahimie, E. (2) 581–608
Hoff, E., see Handels, R.L.H. (3) 875–885
Hoffmann, W., see Eichler, T. (2) 619–629
Hoffmann, W., see Thyrian, J.R. (2) 609–617
Hofmann-Apitius, M., see Iyappan, A. (4) 1343–1360
Hohman, T.J., see Jefferson, A.L. (2) 539–559
Holman, C., see Teich, A.F. (1) 295–302
Holtzman, D.M., see Ingber, A.P. (3) 1055–1064
Homma, A., H. Atarashi, N. Kubota, K. Nakai and T. Takase, Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer’s Disease: A Randomized, Double-Blind Trial (1) 345–357
Hong, Y.J., see Yoon, B. (1) 91–99
Hoogerhout, P., see Mulder, C.K. (3) 1111–1123
Hoogmoed, J., see Handels, R.L.H. (3) 875–885
Hornberger, M., see Ahmed, S. (4) 1245–1250
Hoscheidt, S.M., E.J. Starks, J.M. Oh, H. Zetterberg, K. Blennow, R.A. Krause, C.E. Gleason, L. Puglielli, C.S. Atwood, C.M. Carlsson, S. Asthana, S.C. Johnson and B.B. Bendlin, Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults (4) 1373–1383
Houde, M., see Bensaïdane, M.R. (4) 1251–1262
Hu, L., see Lingler, J.H. (1) 17–24
Hu, Q., W. Teng, J. Li, F. Hao and N. Wang, Homocysteine and Alzheimer’s Disease: Evidence for a Causal Link from Mendelian Randomization (2) 747–756
Huang, H.-C., B.-W. Zheng, Y. Guo, J. Zhao, J.-Y. Zhao, X.-W. Ma and Z.-F. Jiang, Antioxidative and Neuroprotective Effects of Curcumin in an Alzheimer’s Disease Rat Model Co-Treated with Intracerebroventricular Streptozotocin and Subcutaneous D-Galactose (3) 899–911
Huang, X., see Yang, C. (2) 391–402
Huang, X., see Yang, C. (2) 391–402
Huber, H., see Roeben, B. (1) 161–169
Hudon, C., see Callahan, B.L. (2) 451–462
Hughes, C.M., see Barry, H.E. (4) 1503–1513
Hunsaker, A.E., see Lingler, J.H. (1) 17–24
Husain, M., see Ahmed, S. (4) 1245–1250
Hye, A., see Westwood, S. (2) 561–572
Iaccarino, L., S. Marelli, S. Iannaccone, G. Magnani, L. Ferini-Strambi and D. Perani, Severe Brain Metabolic Decreases Associated with REM Sleep Behavior Disorder in Dementia with Lewy Bodies (3) 989–997
Iannaccone, S., see Iaccarino, L. (3) 989–997
Ihara, M., see Hattori, Y. (3) 1037–1045
Ikram, M.K., see Xu, X. (3) 1021–1028
Im, H.K., see Kim, H.-J. (3) 1101–1109
Ingber, A.P., J. Hassenstab, A.M. Fagan, T.L.S. Benzinger, E.A. Grant, D.M. Holtzman, J.C. Morris and C.M. Roe, Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future “Non-Cognitive” Outcomes of Alzheimer’s Disease (3) 1055–1064
Innes, K.E., T.K. Selfe, D.S. Khalsa and S. Kandati, Effects of Meditation versus Music Listening on Perceived Stress, Mood, Sleep, and Quality of Life in Adults with Early Memory Loss: A Pilot Randomized Controlled Trial (4) 1277–1298
Isla, A.G., F.G. Vázquez-Cuevas and F. Peña-Ortega, Exercise Prevents Amyloid-β-Induced Hippocampal Network Disruption by Inhibiting GSK3β Activation (1) 333–343
Ito, K., see Ota, K. (4) 1385–1401
Iyappan, A., M. Gündel, M. Shahid, J. Wang, H. Li, H.-T. Mevissen, B. Müller, J. Fluck, V. Jirsa, L. Domide, E. Younesi and M. Hofmann-Apitius, Towards a Pathway Inventory of the Human Brain for Modeling Disease Mechanisms Underlying Neurodegeneration (4) 1343–1360
Jääskeläinen, J.E., see Koivisto, A.M. (2) 497–507
Jacob-Filho, W., see Cestari, J.A.F. (4) 1479–1485
Jahng, G.-H., J. Oh, D.-W. Lee, H.-G. Kim, H.Y. Rhee, W. Shin, J.-W. Paik, K.M. Lee, S. Park, B.-Y. Choe and C.-W. Ryu, Glutamine and Glutamate Complex, as Measured by Functional Magnetic Resonance Spectroscopy, Alters During Face-Name Association Task in Patients with Mild Cognitive Impairment and Alzheimer’s Disease (1) 145–159
Jak, A.J., see Edmonds, E.C. (2) 685–691
James, M.L., see Berger, M. (4) 1299–1310
Jang, J.-W., see Wang, M.J. (4) 1403–1413
Jansen, W.J., see Handels, R.L.H. (3) 875–885
Jayne, T., M. Newman, G. Verdile, G. Sutherland, G. Münch, I. Musgrave, S.H. Moussavi Nik and M. Lardelli, Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer’s Disease (3) 781–799
Jefferson, A.L., K.A. Gifford, L.M.Y. Acosta, S.P. Bell, M.J. Donahue, L.T. Davis, J.A. Gottlieb, D.K. Gupta, T.J. Hohman, E.M. Lane, D.J. Libon, L.A. Mendes, K. Niswender, K.R. Pechman, S. Rane, F.L. Ruberg, Y.R. Su, H. Zetterberg and D. Liu, The Vanderbilt Memory & Aging Project: Study Design and Baseline Cohort Overview (2) 539–559
Jekel, K., M. Damian, H. Storf, L. Hausner and L. Frölich, Development of a Proxy-Free Objective Assessment Tool of Instrumental Activities of Daily Living in Mild Cognitive Impairment Using Smart Home Technologies (2) 509–517
Ji, C., see Zhu, D. (2) 483–495
Jia, J., see Xing, Y. (3) 1029–1035
Jia, J.-p., see Wang, W. (3) 1089–1099
Jiang, T., see Wang, H.-F. (1) 179–190
Jiang, T., see Yang, C. (2) 391–402
Jiang, T., see Zhan, Y. (3) 913–927
Jiang, Z.-F., see Huang, H.-C. (3) 899–911
Jirsa, V., see Iyappan, A. (4) 1343–1360
John, V., see Spilman, P.R. (1) 223–242
Johnson, S.C., see Hoscheidt, S.M. (4) 1373–1383
Johnston, C.S., see Miller, B.J. (3) 843–847
Joore, M.A., see Handels, R.L.H. (3) 875–885
Jr Laforce, R., see Bensaïdane, M.R. (4) 1251–1262
Kalil, J., see Cestari, J.A.F. (4) 1479–1485
Kandati, S., see Innes, K.E. (4) 1277–1298
Kang, J.H., see Vercambre, M.-N. (3) 887–898
Kang, S.M., see Wang, M.J. (4) 1403–1413
Kapogiannis, D., see El Haj, M. (2) 421–431
Karakaya, T., see Matura, S. (1) 317–331
Kawachi, I., see Vercambre, M.-N. (3) 887–898
Kaye, J.A., see Silbert, L.C. (2) 713–717
Khalsa, D.S., see Eyre, H.A. (2) 673–684
Khalsa, D.S., see Innes, K.E. (4) 1277–1298
Khondoker, M.R., see Westwood, S. (2) 561–572
Kiddle, S.J., see Westwood, S. (2) 561–572
Kim, H.-G., see Jahng, G.-H. (1) 145–159
Kim, H.-J., H.K. Im, J. Kim, J.-y. Han, M. de Leon, A. Deshpande and W.-J. Moon, Brain Atrophy of Secondary REM-Sleep Behavior Disorder in Neurodegenerative Disease (3) 1101–1109
Kim, J., see Kim, H.-J. (3) 1101–1109
Kim, S.Y., see Wang, M.J. (4) 1403–1413
Kim, Y.D., see Yoon, B. (1) 91–99
Kipps, C., see Ahmed, S. (4) 1245–1250
Kivisaari, S.L., see Hirni, D.I. (2) 573–580
Klunk, W.E., see Lingler, J.H. (1) 17–24
Knöchel, C., see Matura, S. (1) 317–331
Kochan, N.A., see Heffernan, M. (2) 529–538
Kofanova, O., see Lelental, N. (1) 51–64
Koike, W., see Sekiyama, K. (3) 831–841
Koivisto, A.M., M.I. Kurki, I. Alafuzoff, A. Sutela, J. Rummukainen, S. Savolainen, R. Vanninen, J.E. Jääskeläinen, H. Soininen and V. Leinonen, High Risk of Dementia in Ventricular Enlargement with Normal Pressure Hydrocephalus Related Symptoms (2) 497–507
Kong, L., see Zeng, L. (3) 813–823
Kornhuber, J., see Lelental, N. (1) 51–64
Kösel, J., see Küster, O.C. (2) 519–528
Koudys, J., see Smart, C.M. (2) 757–774
Kovacech, B., see Lelental, N. (1) 51–64
Krause, R.A., see Hoscheidt, S.M. (4) 1373–1383
Kressig, R.W., see Hirni, D.I. (2) 573–580
Krumm, S., see Hirni, D.I. (2) 573–580
Kubota, N., see Homma, A. (1) 345–357
Kuiperij, H.B., see Müller, M. (4) 1321–1333
Kuller, L.H., see Raji, C.A. (2) 719–729
Kurki, M.I., see Koivisto, A.M. (2) 497–507
Kurrle, S., see Connors, M.H. (3) 967–974
Küster, O.C., J. Kösel, S. Spohn, N. Schurig, H. Tumani, C.A.F. von Arnim and I. Uttner, Cognitive Reserve in Alzheimer’s Dementia: Diagnostic Accuracy of a Testing-the-Limits Paradigm (2) 519–528
Kwak, K., see Ye, B.S. (4) 1237–1243
Labonte, A., see Lelental, N. (1) 51–64
Labra-Barrios, M.L., see Ontiveros-Torres, M.Á. (1) 243–269
Lacasse-Champagne, A., see Bier, N. (4) 1361–1371
Laforce, Jr. R. see Callahan, B.L. (2) 451–462
Lagergren, M., see Pimouguet, C. (1) 213–222
Lahna, D., see Silbert, L.C. (2) 713–717
Lane, E.M., see Jefferson, A.L. (2) 539–559
Lanhers, M.-C., see Colin, J. (3) 975–987
Lanzillotta, C., see Tramutola, A. (1) 359–371
Lardelli, M., see Ebrahimie, E. (2) 581–608
Lardelli, M., see Jayne, T. (3) 781–799
Laske, C., see Gardener, S.L. (2) 661–672
Laskowitz, D.T., see Berger, M. (4) 1299–1310
Lavretsky, H., see Eyre, H.A. (2) 673–684
Laws, S.M., see Gardener, S.L. (2) 661–672
Leaver, A.M., see Eyre, H.A. (2) 673–684
le-Bouc, Y., see Vidal, J.-S. (2) 641–649
Lebrec, J., see Henneges, C. (3) 1065–1080
Lee, D.-W., see Jahng, G.-H. (1) 145–159
Lee, J.J., see Ye, B.S. (4) 1237–1243
Lee, J.-M., see Ye, B.S. (4) 1237–1243
Lee, K.M., see Jahng, G.-H. (1) 145–159
Lee, P.H., see Ye, B.S. (4) 1237–1243
Lee, Y., see Ye, B.S. (4) 1237–1243
Leentjens, A.F.G., see Handels, R.L.H. (3) 875–885
Lehmann, S., see Lelental, N. (1) 51–64
Leibovitz, A., see Shindler-Itskovitch, T. (4) 1431–1442
Leinonen, V., see Koivisto, A.M. (2) 497–507
Lelental, N., S. Brandner, O. Kofanova, K. Blennow, H. Zetterberg, U. Andreasson, S. Engelborghs, B. Mroczko, T. Gabryelewicz, C. Teunissen, B. Mollenhauer, L. Parnetti, D. Chiasserini, J.L. Molinuevo, A. Perret-Liaudet, M.M. Verbeek, N. Andreasen, F. Brosseron, J.M.C. Bahl, S.-K. Herukka, L. Hausner, L. Frölich, A. Labonte, J. Poirier, A.-M. Miller, N. Zilka, B. Kovacech, A. Urbani, S. Suardi, C. Oliveira, I. Baldeiras, B. Dubois, U. Rot, S. Lehmann, A. Skinningsrud, F. Betsou, J. Wiltfang, O. Gkatzima, B. Winblad, M. Buchfelder, J. Kornhuber and P. Lewczuk, Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics (1) 51–64
Lenzo, N., see Gardener, S.L. (2) 661–672
Leoni, E., see Westwood, S. (2) 561–572
Lethagen, E., see Nilsson, E.D. (3) 1047–1053
Leung, R., see Westwood, S. (2) 561–572
Lewczuk, P., see Lelental, N. (1) 51–64
Leyhe, T., see Müller, S. (4) 1215–1225
Li, H., see Iyappan, A. (4) 1343–1360
Li, J., see Hu, Q. (2) 747–756
Li, J., see Tang, S.-S. (4) 1157–1175
Li, J., see Yang, C. (2) 391–402
Li, W., see Zeng, L. (3) 813–823
Li, X., see Zeng, L. (3) 813–823
Li, X., Y. Song, C.R. Sanders and J.N. Buxbaum, Transthyretin Suppresses Amyloid-β Secretion by Interfering with Processing of the Amyloid-β Protein Precursor (4) 1263–1275
Liang, T., see Meng, X. (3) 1135–1150
Liang, W., see Wang, N. (3) 829–830
Liang, W., see Zeng, L. (3) 813–823
Libon, D.J., see Bangen, K.J. (3) 849–861
Libon, D.J., see Jefferson, A.L. (2) 539–559
Lim, K.T., see Wang, M.J. (4) 1403–1413
Lingler, J.H., M.A. Butters, A.L. Gentry, L. Hu, A.E. Hunsaker, W.E. Klunk, M.K. Mattos, L.A. Parker, J.S. Roberts and R. Schulz, Development of a Standardized Approach to Disclosing Amyloid Imaging Research Results in Mild Cognitive Impairment (1) 17–24
Liu, C.-H., X.-L. Bu, J. Wang, T. Zhang, Y. Xiang, L.-L. Shen, Q.-H. Wang, B. Deng, X. Wang, C. Zhu, X.-Q. Yao, M. Zhang, H.-D. Zhou and Y.-J. Wang, The Associations between a Capsaicin-Rich Diet and Blood Amyloid-β Levels and Cognitive Function (3) 1081–1088
Liu, D., see Jefferson, A.L. (2) 539–559
Liu, J., see Wang, N. (3) 829–830
Liu, J., see Zeng, L. (3) 813–823
Liu, Y., see Zhan, Y. (3) 913–927
Liu, Y.-Y., see Zhu, D. (2) 483–495
Longstreth Jr., W.T., see Raji, C.A. (2) 719–729
Lopes, J., M. Correia, I. Martins, A.G. Henriques, I. Delgadillo, O. da Cruz e Silva and A. Nunes, FTIR and Raman Spectroscopy Applied to Dementia Diagnosis Through Analysis of Biological Fluids (3) 801–812
López, M.E., A. Turrero, P. Cuesta, D. López-Sanz, R. Bruña, A. Marcos, P. Gil, M. Yus, A. Barabash, J.A. Cabranes, F. Maestú and A. Fernández, Searching for Primary Predictors of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease: A Multivariate Follow-Up Study (1) 133–143
Lopez, O.L., see Raji, C.A. (2) 719–729
Lopez-Font, I., see Cuchillo-Ibañez, I. (2) 403–416
López-Sanz, D., see López, M.E. (1) 133–143
Lorenzo-López, L., see Sánchez, A. (1) 303–315
Lovestone, S., see Westwood, S. (2) 561–572
Lu, L., see Wang, W. (3) 1089–1099
Lü, T., see Yang, C. (2) 391–402
Luna-Arias, J.P., see Ontiveros-Torres, M.Á. (1) 243–269
Luna-Herrera, C., see Ontiveros-Torres, M.Á. (1) 243–269
Luna-Muñoz, J., see Ontiveros-Torres, M.Á. (1) 243–269
Luo, Y., see Meng, X. (3) 1135–1150
Luyckx, J., see Müller, M. (4) 1321–1333
Lyketsos, C.G., see Sanders, C. (1) 33–42
Lynham, S., see Westwood, S. (2) 561–572
Ma, J., see Zhan, Y. (3) 913–927
Ma, X.-W., see Huang, H.-C. (3) 899–911
Maestú, F., see Fernández-Blázquez, M.A. (1) 271–281
Maestú, F., see López, M.E. (1) 133–143
Maetzler, W., see Roeben, B. (1) 161–169
Magnani, G., see Clarelli, F. (4) 1203–1208
Magnani, G., see Iaccarino, L. (3) 989–997
Mai, H., see Yang, C. (2) 391–402
Maki, T., see Hattori, Y. (3) 1037–1045
Malaplate-Armand, C., see Colin, J. (3) 975–987
Mallam, S., see Raji, C.A. (2) 719–729
Mammana, L., see Palmeri, A. (1) 65–75
Mander, A., see Connors, M.H. (3) 967–974
Manly, J.J., see Zahodne, L.B. (3) 1013–1020
Marante-Moar, M.P., see Sánchez, A. (1) 303–315
Marcos, A., see López, M.E. (1) 133–143
Marelli, S., see Iaccarino, L. (3) 989–997
Martinez-Ramirez, S., see Xiong, L. (1) 171–178
Martin-Hunyadi, C., see Cretin, B. (3) 1125–1133
Martins, I., see Lopes, J. (3) 801–812
Martins, R.N., see Gardener, S.L. (2) 661–672
Mascia, E., see Clarelli, F. (4) 1203–1208
Maseda, A., see Sánchez, A. (1) 303–315
Masliah, E., see Waragai, M. (4) 1453–1459
Masramon, X., see Gramunt, N. (1) 283–293
Mata-Balaguer, T., see Cuchillo-Ibañez, I. (2) 403–416
Mather, K.A., see Heffernan, M. (2) 529–538
Mathew, J.P., see Berger, M. (4) 1299–1310
Mattek, N., see Silbert, L.C. (2) 713–717
Mattos, M.K., see Lingler, J.H. (1) 17–24
Matura, S., D. Prvulovic, D. Hartmann, M. Scheibe, B. Sepanski, M. Butz, V. Oertel-Knöchel, C. Knöchel, T. Karakaya, F. Fußer, E. Hattingen and J. Pantel, Age-Related Effects of the Apolipo-protein E Gene on Brain Function (1) 317–331
Mayeux, R., see Zahodne, L.B. (3) 1013–1020
Mazzeo, S., see Clarelli, F. (4) 1203–1208
McDonagh, D.L., see Berger, M. (4) 1299–1310
McGeehan, A., see Spilman, P.R. (1) 223–242
Medina, M., see Fernández-Blázquez, M.A. (1) 271–281
Mehlen, P., see Spilman, P.R. (1) 223–242
Melander, O., see Nilsson, E.D. (3) 1047–1053
Melcher, T., see Müller, S. (4) 1215–1225
Mena, R., see Ontiveros-Torres, M.Á. (1) 243–269
Mendes, L.A., see Jefferson, A.L. (2) 539–559
Meng, X., Y. Luo, T. Liang, M. Wang, J. Zhao, G. Sun and X. Sun, Gypenoside XVII Enhances Lysosome Biogenesis and Autophagy Flux and Accelerates Autophagic Clearance of Amyloid-β through TFEB Activation (3) 1135–1150
Merrill, D.A., see Raji, C.A. (2) 719–729
Messier, C., see Bier, N. (4) 1361–1371
Mevissen, H.-T., see Iyappan, A. (4) 1343–1360
Mi, S., see Zeng, L. (3) 813–823
Miao, D., see Tan, C.-C. (1) 43–50
Michalowsky, B., see Eichler, T. (2) 619–629
Michalowsky, B., see Thyrian, J.R. (2) 609–617
Millán-Calenti, J.C., see Sánchez, A. (1) 303–315
Miller, A.-M., see Lelental, N. (1) 51–64
Miller, B.J., C.M. Whisner and C.S. Johnston, Vitamin D Supplementation Appears to Increase Plasma Aβ40 in Vitamin D Insufficient Older Adults: A Pilot Randomized Controlled Trial (3) 843–847
Min, J.-y. and K.-b. Min, The Folate-Vitamin B12 Interaction, Low Hemoglobin, and the Mortality Risk from Alzheimer’s Disease (2) 705–712
Min, K.-b., see Min, J.-y. (2) 705–712
Minthon, L., see Nilsson, E.D. (3) 1047–1053
Mioshi, E., see Bier, N. (4) 1361–1371
Molinuevo, J.L., see Gramunt, N. (1) 283–293
Molinuevo, J.L., see Lelental, N. (1) 51–64
Mollenhauer, B., see Lelental, N. (1) 51–64
Molloy, G.J., see Barry, H.E. (4) 1503–1513
Monsch, A.U., see Hirni, D.I. (2) 573–580
Moon, W.-J., see Kim, H.-J. (3) 1101–1109
Moreno-Campuzano, S., see Ontiveros-Torres, M.Á. (1) 243–269
Morihara, R., see Shang, J. (1) 113–126
Morihara, R., see Zhai, Y. (4) 1311–1319
Morris, J.C., see Allison, S.L. (1) 77–90
Morris, J.C., see Ingber, A.P. (3) 1055–1064
Mouiha, A., see Callahan, B.L. (2) 451–462
Moussavi Nik, S.H., see Jayne, T. (3) 781–799
Mroczko, B., see Lelental, N. (1) 51–64
Muhsen, K., see Shindler-Itskovitch, T. (4) 1431–1442
Mulder, C.K., Y. Dong, H.F. Brugghe, H.A.M. Timmermans, W. Tilstra, J. Westdijk, E. van Riet, H. van Steeg, P. Hoogerhout and U.L.M. Eisel, Immunization with Small Amyloid-β-derived Cyclopeptide Conjugates Diminishes Amyloid-β-Induced Neurodegeneration in Mice (3) 1111–1123
Müller, B., see Iyappan, A. (4) 1343–1360
Müller, M., H.B. Kuiperij, A.A.M. Versleijen, D. Chiasserini, L. Farotti, F. Baschieri, L. Parnetti, H. Struyfs, N. De Roeck, J. Luyckx, S. Engelborghs, J.A. Claassen and M.M. Verbeek, Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study (4) 1321–1333
Müller, S., C. Mychajliw, C. Reichert, T. Melcher and T. Leyhe, Autobiographical Memory Performance in Alzheimer’s Disease Depends on Retrieval Frequency (4) 1215–1225
Mulligan, B.P., see Smart, C.M. (2) 757–774
Münch, G., see Jayne, T. (3) 781–799
Musgrave, I., see Jayne, T. (3) 781–799
Mychajliw, C., see Müller, S. (4) 1215–1225
Nadler, J.W., see Berger, M. (4) 1299–1310
Nagatsuka, K., see Hattori, Y. (3) 1037–1045
Nägga, K., see Nilsson, E.D. (3) 1047–1053
Nakai, K., see Homma, A. (1) 345–357
Nakano, Y., see Shang, J. (1) 113–126
Nakano, Y., see Zhai, Y. (4) 1311–1319
Narr, K., see Eyre, H.A. (2) 673–684
Nation, D.A., see Bangen, K.J. (3) 849–861
Nelson, P.T., see Nho, K. (1) 373–383
Newman, M., see Ebrahimie, E. (2) 581–608
Newman, M., see Jayne, T. (3) 781–799
Newman, M.F., see Berger, M. (4) 1299–1310
Nho, K., A.J. Saykin, Alzheimer’s Disease Neuroimaging Initiative, and P.T. Nelson, Hippocampal Sclerosis of Aging, a Common Alzheimer’s Disease ‘Mimic’: Risk Genotypes are Associated with Brain Atrophy Outside the Temporal Lobe (1) 373–383
Niebler, R., see Roeben, B. (1) 161–169
Nik, S.H.M., see Ebrahimie, E. (2) 581–608
Nilsson, E.D., O. Melander, S. Elmståhl, E. Lethagen, L. Minthon, M. Pihlsgård and K. Nägga, Copeptin, a Marker of Vasopressin, Predicts Vascular Dementia but not Alzheimer’s Disease (3) 1047–1053
Niswender, K., see Jefferson, A.L. (2) 539–559
Nitrini, R., see Cestari, J.A.F. (4) 1479–1485
Noortgate, N.V.D., see Vandepitte, S. (3) 929–965
Nunes, A., see Lopes, J. (3) 801–812
Oeksuez, F., see Hirni, D.I. (2) 573–580
Oertel-Knöchel, V., see Matura, S. (1) 317–331
Oh, J., see Jahng, G.-H. (1) 145–159
Oh, J.M., see Hoscheidt, S.M. (4) 1373–1383
Ohta, Y., see Shang, J. (1) 113–126
Ohta, Y., see Takemoto, M. (1) 205–211
Ohta, Y., see Zhai, Y. (4) 1311–1319
Oishi, N., see Ota, K. (4) 1385–1401
Okereke, O.I., see Vercambre, M.-N. (3) 887–898
Oliveira, C., see Lelental, N. (1) 51–64
Olivié, L., see Gómez-Tortosa, E. (1) 25–31
Olya, H.G.T., see Beheshti, I. (4) 1335–1342
Ontiveros-Torres, M.Á., M.L. Labra-Barrios, S. Díaz-Cintra, A.R. Aguilar-Vázquez, S. Moreno-Campuzano, P. Flores-Rodríguez, C. Luna-Herrera, R. Mena, G. Perry, B. Florán-Garduño, J. Luna-Muñoz and J.P. Luna-Arias, Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse (1) 243–269
Oster, T., see Colin, J. (3) 975–987
Ota, K., N. Oishi, K. Ito, H. Fukuyama and SEAD-J Study Group, for the Alzheimer’s Disease Neuroimaging Initiative, Prediction of Alzheimer’s Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers (4) 1385–1401
Otto, G.P., D. Sharma and R.S.B. Williams, Non-Catalytic Roles of Presenilin Throughout Evolution (4) 1177–1187
Padovani, A., see Premi, E. (4) 1227–1235
Paik, J.-W., see Jahng, G.-H. (1) 145–159
Palmeri, A., L. Mammana, M.R. Tropea, W. Gulisano and D. Puzzo, Salidroside, a Bioactive Compound of Rhodiola Rosea, Ameliorates Memory and Emotional Behavior in Adult Mice (1) 65–75
Pan, J., see Zeng, L. (3) 813–823
Pantel, J., see Matura, S. (1) 317–331
Paquette, G., see Bier, N. (4) 1361–1371
Park, H.K., see Yoon, B. (1) 91–99
Park, S., see Jahng, G.-H. (1) 145–159
Park, S.A., see Yoon, B. (1) 91–99
Park, S.Y., see Wang, M.J. (4) 1403–1413
Park, Y.H., see Wang, M.J. (4) 1403–1413
Park, Y.-H., see Ye, B.S. (4) 1237–1243
Parker, L.A., see Lingler, J.H. (1) 17–24
Parnetti, L., see Lelental, N. (1) 51–64
Parnetti, L., see Müller, M. (4) 1321–1333
Passmore, A.P., see Barry, H.E. (4) 1503–1513
Patel, M., see Teich, A.F. (1) 295–302
Pauron-Gregory, L., see Colin, J. (3) 975–987
Pechman, K.R., see Jefferson, A.L. (2) 539–559
Pedersen, J.T., see Schütt, T. (2) 433–449
Pedersen, L.Ø., see Schütt, T. (2) 433–449
Pellerin, M.-L., see Bier, N. (4) 1361–1371
Peña-Casanova, J., see Gramunt, N. (1) 283–293
Peña-Ortega, F., see Isla, A.G. (1) 333–343
Perani, D., see Iaccarino, L. (3) 989–997
Pereira, F.C., see Rego, Â. (4) 1189–1202
Perez, J.J., see Fernandez, A.M. (4) 1471–1478
Pérez-Pérez, J., see Gómez-Tortosa, E. (1) 25–31
Perluigi, M., see Tramutola, A. (1) 359–371
Perret-Liaudet, A., see Lelental, N. (1) 51–64
Perry, G., see Ontiveros-Torres, M.Á. (1) 243–269
Peters-Libeu, C., see Spilman, P.R. (1) 223–242
Petit, M., see Bier, N. (4) 1361–1371
Philippi, N., see Cretin, B. (3) 1125–1133
Piazza, F. and B. Winblad, Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer’s Disease: Need for Prognostic Biomarkers? (2) 417–420
Pihlsgård, M., see Nilsson, E.D. (3) 1047–1053
Pimouguet, C., D. Rizzuto, J. Fastbom, M. Lagergren, L. Fratiglioni and W. Xu, Influence of Incipient Dementia on Hospitalization for Primary Care Sensitive Conditions: A Population-Based Cohort Study (1) 213–222
Pliássova, A., P.M. Canas, A.C. Xavier, B.S. da Silva, R.A. Cunha and P. Agostinho, Age-Related Changes in the Synaptic Density of Amyloid-β Protein Precursor and Secretases in the Human Cerebral Cortex (4) 1209–1214
Poirier, J., see Lelental, N. (1) 51–64
Poksay, K.S., see Spilman, P.R. (1) 223–242
Ponnusamy, V., see Berger, M. (4) 1299–1310
Portellano-Ortiz, C., see Conde-Sala, J.L. (3) 999–1012
Poulin, S., see Bensaïdane, M.R. (4) 1251–1262
Premi, E., V. Gualeni, P. Costa, M. Cosseddu, R. Gasparotti, A. Padovani and B. Borroni, Looking for Measures of Disease Severity in the Frontotemporal Dementia Continuum (4) 1227–1235
Prieto-Jurczynska, C., see Gómez-Tortosa, E. (1) 25–31
Promjunyakul, N., see Silbert, L.C. (2) 713–717
Prvulovic, D., see Matura, S. (1) 317–331
Puglielli, L., see Hoscheidt, S.M. (4) 1373–1383
Pupo, G., see Tramutola, A. (1) 359–371
Putman, K., see Vandepitte, S. (3) 929–965
Puzzo, D., see Palmeri, A. (1) 65–75
Qi, W., see Berger, M. (4) 1299–1310
Qin, W., see Xing, Y. (3) 1029–1035
Rainey-Smith, S.R., see Gardener, S.L. (2) 661–672
Raji, C.A., D.A. Merrill, H. Eyre, S. Mallam, N. Torosyan, K.I. Erickson, O.L. Lopez, J.T. Becker, O.T. Carmichael, H.M. Gach, P.M. Thompson, W.T. Longstreth, Jr. and L.H. Kuller, Longitudinal Relationships between Caloric Expenditure and Gray Matter in the Cardiovascular Health Study (2) 719–729
Ramakers, I.H.G.B., see Handels, R.L.H. (3) 875–885
Ramos-Goicoa, M., S. Galdo-Álvarez, F. Díaz and M. Zurrón, Effect of Normal Aging and of Mild Cognitive Impairment on Event-Related Potentials to a Stroop Color-Word Task (4) 1487–1501
Rane, S., see Jefferson, A.L. (2) 539–559
Rao, R., see Spilman, P.R. (1) 223–242
Ravona-Springer, R., see Shindler-Itskovitch, T. (4) 1431–1442
Reed, C., see Henneges, C. (3) 1065–1080
Rego, Â., S.D. Viana, C.A.F. Ribeiro, P. Rodrigues-Santos and F.C. Pereira, Monophosphoryl Lipid-A: A Promising Tool for Alzheimer’s Disease Toll (4) 1189–1202
Reichert, C., see Müller, S. (4) 1215–1225
Reijmer, Y.D., see Xiong, L. (1) 171–178
Reimann, M., see Thyrian, J.R. (2) 609–617
Reinhardt, J., see Hirni, D.I. (2) 573–580
Reñé-Ramírez, R., see Conde-Sala, J.L. (3) 999–1012
Reppermund, S., see Heffernan, M. (2) 529–538
Rhee, H.Y., see Jahng, G.-H. (1) 145–159
Ribeiro, C.A.F., see Rego, Â. (4) 1189–1202
Richter, S., see Eichler, T. (2) 619–629
Richter, S., see Thyrian, J.R. (2) 609–617
Rigaud, A.-S., see Vidal, J.-S. (2) 641–649
Rikkert, M.O., see Handels, R.L.H. (3) 875–885
Ripova, D., see Torres-Cruz, F.M. (2) 463–482
Rizzuto, D., see Pimouguet, C. (1) 213–222
Roberts, J.S., see Lingler, J.H. (1) 17–24
Robinson, A.L., see Barry, H.E. (4) 1503–1513
Rodrigues-Santos, P., see Rego, Â. (4) 1189–1202
Rodríguez-Cruz, F., see Torres-Cruz, F.M. (2) 463–482
Roe, C.M., see Ingber, A.P. (3) 1055–1064
Roeben, B., W. Maetzler, E. Vanmechelen, C. Schulte, S. Heinzel, K. Stellos, J. Godau, H. Huber, K. Brockmann, I. Wurster, A. Gaenslen, E. Grüner, R. Niebler, G.W. Eschweiler and D. Berg and the TREND study team, Association of Plasma Aβ40 Peptides, But Not Aβ42, with Coronary Artery Disease and Diabetes Mellitus (1) 161–169
Roongpiboonsopit, D., see Xiong, L. (1) 171–178
Rosenberg, J., Approaches to Increasing Ethical Compliance in China with Drug Trial Standards of Practice (3) 825–827
Rostant, O.S., see Beydoun, M.A. (4) 1415–1430
Rot, U., see Lelental, N. (1) 51–64
Rousseau, F., see Callahan, B.L. (2) 451–462
Ruberg, F.L., see Jefferson, A.L. (2) 539–559
Ruiz, P.G., see Gómez-Tortosa, E. (1) 25–31
Rummukainen, J., see Koivisto, A.M. (2) 497–507
Ryan, C., see Barry, H.E. (4) 1503–1513
Ryu, C.-W., see Jahng, G.-H. (1) 145–159
Sachdev, P., see Heffernan, M. (2) 529–538
Saeed, F., see Teich, A.F. (1) 295–302
Sáez-Valero, J., see Cuchillo-Ibañez, I. (2) 403–416
Sainz, M.J., see Gómez-Tortosa, E. (1) 25–31
Sainz-Fuertes, R., see Westwood, S. (2) 561–572
Saito, S., see Hattori, Y. (3) 1037–1045
Sakurai, M., see Teich, A.F. (1) 295–302
Salmon, D.P., see Edmonds, E.C. (2) 685–691
Salvado, O., see Gardener, S.L. (2) 661–672
Sánchez, A., A. Maseda, M.P. Marante-Moar, C. de Labra, L. Lorenzo-López and J.C. Millán-Calenti, Comparing the Effects of Multisensory Stimulation and Individualized Music Sessions on Elderly People with Severe Dementia: A Randomized Controlled Trial (1) 303–315
Sánchez-Benavides, G., see Gramunt, N. (1) 283–293
Sanders, C., S. Behrens, S. Schwartz, H. Wengreen, C.D. Corcoran, C.G. Lyketsos and J.T. Tschanz, Nutritional Status is Associated with Faster Cognitive Decline and Worse Functional Impairment in the Progression of Dementia: The Cache County Dementia Progression Study (1) 33–42
Sanders, C.R., see Li, X. (4) 1263–1275
Santangelo, R., see Clarelli, F. (4) 1203–1208
Sato, K., see Takemoto, M. (1) 205–211
Savolainen, S., see Koivisto, A.M. (2) 497–507
Saykin, A.J., see Nho, K. (1) 373–383
Scarpini, E., see Clarelli, F. (4) 1203–1208
Scheibe, M., see Matura, S. (1) 317–331
Scheltens, P., see Handels, R.L.H. (3) 875–885
Schulte, C., see Roeben, B. (1) 161–169
Schulz, R., see Lingler, J.H. (1) 17–24
Schupf, N., see Zahodne, L.B. (3) 1013–1020
Schurig, N., see Küster, O.C. (2) 519–528
Schütt, T., L. Helboe, L.Ø. Pedersen, G. Waldemar, M. Berendt and J.T. Pedersen, Dogs with Cognitive Dysfunction as a Spontaneous Model for Early Alzheimer’s Disease: A Translational Study of Neuropathological and Inflammatory Markers (2) 433–449
Schwartz, S., see Sanders, C. (1) 33–42
Segalowitz, S.J., see Smart, C.M. (2) 757–774
Sekiyama, K., see Waragai, M. (4) 1453–1459
Sekiyama, K., Y. Takamatsu, W. Koike, M. Waragai, T. Takenouchi, S. Sugama and M. Hashimoto, Insight into the Dissociation of Behavior from Histology in Synucleinopathies and in Related Neurodegenerative Diseases (3) 831–841
Selfe, T.K., see Innes, K.E. (4) 1277–1298
Sellal, F., see Cretin, B. (3) 1125–1133
Sepanski, B., see Matura, S. (1) 317–331
Serrano, S., see Gómez-Tortosa, E. (1) 25–31
Seux, M.-L., see Vidal, J.-S. (2) 641–649
Severens, J.L., see Handels, R.L.H. (3) 875–885
Shah, T., see Gardener, S.L. (2) 661–672
Shahid, M., see Iyappan, A. (4) 1343–1360
Shang, J., T. Yamashita, Y. Zhai, Y. Nakano, R. Morihara, Y. Fukui, N. Hishikawa, Y. Ohta and K. Abe, Strong Impact of Chronic Cerebral Hypoperfusion on Neurovascular Unit, Cerebrovascular Remodeling, and Neurovascular Trophic Coupling in Alzheimer’s Disease Model Mouse (1) 113–126
Sharma, D., see Otto, G.P. (4) 1177–1187
Shaw, L.M., see Berger, M. (4) 1299–1310
Shen, K.-k., see Gardener, S.L. (2) 661–672
Shen, L.-L., see Liu, C.-H. (3) 1081–1088
Shi, J., see Han, P. (4) 1461–1470
Shi, X., see Zhang, X. (1) 101–111
Shim, Y.S., see Yoon, B. (1) 91–99
Shin, N.-Y., see Ye, B.S. (4) 1237–1243
Shin, W., see Jahng, G.-H. (1) 145–159
Shindler-Itskovitch, T., R. Ravona-Springer, A. Leibovitz and K. Muhsen, A Systematic Review and Meta-Analysis of the Association between Helicobacter pylori Infection and Dementia (4) 1431–1442
Shoamanesh, A., see Xiong, L. (1) 171–178
Siddarth, P., see Eyre, H.A. (2) 673–684
Silbert, L.C., H.H. Dodge, D. Lahna, N. Promjunyakul, D. Austin, N. Mattek, D. Erten-Lyons and J.A. Kaye, Less Daily Computer Use is Related to Smaller Hippocampal Volumes in Cognitively Intact Elderly (2) 713–717
Simard, M., see Callahan, B.L. (2) 451–462
Siqueira, S.R.D.T., see Cestari, J.A.F. (4) 1479–1485
Skinningsrud, A., see Lelental, N. (1) 51–64
Smart, C.M., S.J. Segalowitz, B.P. Mulligan, J. Koudys and J.R. Gawryluk, Mindfulness Training for Older Adults with Subjective Cognitive Decline: Results from a Pilot Randomized Controlled Trial (2) 757–774
Smid, M., see Handels, R.L.H. (3) 875–885
Smith, A., see Beach, T.G. (3) 863–873
Sohn, Y.H., see Ye, B.S. (4) 1237–1243
Sohrabi, H.R., see Gardener, S.L. (2) 661–672
Soininen, H., see Koivisto, A.M. (2) 497–507
Song, Y., see Li, X. (4) 1263–1275
Soucy, J.-P., see Bensaïdane, M.R. (4) 1251–1262
Spilman, P.R., V. Corset, O. Gorostiza, K.S. Poksay, V. Galvan, J. Zhang, R. Rao, C. Peters-Libeu, J. Vincelette, A. McGeehan, M. Dvorak-Ewell, J. Beyer, J. Campagna, K. Bankiewicz, P. Mehlen, V. John and D.E. Bredesen, Netrin-1 Interrupts Amy-loid-β Amplification, Increases sAβPPα in vitro and in vivo, and Improves Cognition in a Mouse Model of Alzheimer’s Disease (1) 223–242
Spohn, S., see Küster, O.C. (2) 519–528
Starks, E.J., see Hoscheidt, S.M. (4) 1373–1383
Stellos, K., see Roeben, B. (1) 161–169
Stern, Y., see Zahodne, L.B. (3) 1013–1020
Stippich, C., see Hirni, D.I. (2) 573–580
Storf, H., see Jekel, K. (2) 509–517
Struyfs, H., see Müller, M. (4) 1321–1333
Su, Y.R., see Jefferson, A.L. (2) 539–559
Suardi, S., see Lelental, N. (1) 51–64
Sugama, S., see Sekiyama, K. (3) 831–841
Sun, F.-R., see Tan, C.-C. (1) 43–50
Sun, F.-R., see Zhao, Q.-F. (2) 693–703
Sun, G., see Meng, X. (3) 1135–1150
Sun, X., see Meng, X. (3) 1135–1150
Sun, Z., see Zhai, Y. (4) 1311–1319
Sutela, A., see Koivisto, A.M. (2) 497–507
Sutherland, G., see Jayne, T. (3) 781–799
Taddei, K., see Gardener, S.L. (2) 661–672
Taipale, H., see Tiihonen, M. (1) 127–132
Takamatsu, Y., see Sekiyama, K. (3) 831–841
Takamatsu, Y., see Waragai, M. (4) 1453–1459
Takase, T., see Homma, A. (1) 345–357
Takemoto, M., K. Sato, N. Hatanaka, T. Yamashita, Y. Ohta, N. Hishikawa and K. Abe, Different Clinical and Neu-roimaging Characteristics in Early Stage Parkinson’s Disease with Dementia and Dementia with Lewy Bodies (1) 205–211
Takenouchi, T., see Sekiyama, K. (3) 831–841
Tan, C.-C., see Zhao, Q.-F. (2) 693–703
Tan, C.-C., Y. Wan, M.-S. Tan, W. Zhang, Z.-X. Wang, F.-R. Sun, D. Miao, L. Tan and J.-T. Yu, Association of Frontotemporal Dementia GWAS Loci with Late-Onset Alzheimer’s Disease in a Northern Han Chinese Population (1) 43–50
Tan, L., see Tan, C.-C. (1) 43–50
Tan, L., see Tang, S.-S. (4) 1157–1175
Tan, L., see Wang, H.-F. (1) 179–190
Tan, L., see Wang, H.-F. (1) 179–190
Tan, L., see Zhao, Q.-F. (2) 693–703
Tan, M.-S., see Tan, C.-C. (1) 43–50
Tan, M.-S., see Wang, H.-F. (1) 179–190
Tan, M.-S., see Zhao, Q.-F. (2) 693–703
Tang, S.-S., J. Li, L. Tan and J.-T. Yu, Genetics of Frontotemporal Lobar Degeneration: From the Bench to the Clinic (4) 1157–1175
Tang, Y., see Xing, Y. (3) 1029–1035
Tanifum, E.A., K. Ghaghada, C. Vollert, E. Head, J.L. Eriksen and A. Annapragada, A Novel Liposomal Nanoparticle for the Imaging of Amyloid Plaque by Magnetic Resonance Imaging (2) 731–745
Tanskanen, A., see Tiihonen, M. (1) 127–132
Taylor, K.I., see Hirni, D.I. (2) 573–580
Teich, A.F., M. Sakurai, M. Patel, C. Holman, F. Saeed, J. Fiorito and O. Arancio, PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease (1) 295–302
Teipel, S., M.J. Grothe and for the Alzheimer’s Disease Neuroimaging Initiative, Association Between Smoking and Cholinergic Basal Forebrain Volume in Healthy Aging and Prodromal and Dementia Stages of Alzheimer’s Disease (4) 1443–1451
Teng, W., see Hu, Q. (2) 747–756
Teunissen, C., see Lelental, N. (1) 51–64
Thal, D.R., see Beach, T.G. (3) 863–873
Thambisetty, M., see Westwood, S. (2) 561–572
Thanprasertsuk, S., see Xiong, L. (1) 171–178
Thompson, P.M., see Raji, C.A. (2) 719–729
Thompson, S., see Ahmed, S. (4) 1245–1250
Thyrian, J.R., see Eichler, T. (2) 619–629
Thyrian, J.R., T. Eichler, B. Michalowsky, D. Wucherer, M. Reimann, J. Hertel, S. Richter, A. Dreier and W. Hoffmann, Community-Dwelling People Screened Positive for Dementia in Primary Care: A Comprehensive, Multivariate Descriptive Analysis Using Data from the DelpHi-Study (2) 609–617
Tiihonen, J., see Tiihonen, M. (1) 127–132
Tiihonen, M., H. Taipale, A. Tanskanen, J. Tiihonen and S. Hartikainen, Incidence and Duration of Cumulative Bisphosphonate Use among Community-Dwelling Persons with or without Alzheimer’s Disease (1) 127–132
Tilstra, W., see Mulder, C.K. (3) 1111–1123
Timmermans, H.A.M., see Mulder, C.K. (3) 1111–1123
Torosyan, N., see Raji, C.A. (2) 719–729
Torres-Cruz, F.M., F. Rodríguez-Cruz, J. Escobar-Herrera, N. Barragán-Andrade, G. Basurto-Islas, D. Ripova, J. Ávila and F. Garcia-Sierra, Expression of Tau Produces Aberrant Plasma Membrane Blebbing in Glial Cells Through RhoA-ROCK-Dependent F-Actin Remodeling (2) 463–482
Tramutola, A., G. Pupo, F. Di Domenico, E. Barone, A. Arena, C. Lanzillotta, D. Broekaart, C. Blarzino, E. Head, D.A. Butterfield and M. Perluigi, Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype (1) 359–371
Trinh, I., see Waragai, M. (4) 1453–1459
Trollor, J.N. , see Heffernan, M. (2) 529–538
Tropea, M.R., see Palmeri, A. (1) 65–75
Trujillo-Tiebas, M.J., see Gómez-Tortosa, E. (1) 25–31
Tschanz, J.T., see Sanders, C. (1) 33–42
Tumani, H., see Küster, O.C. (2) 519–528
Turrero, A., see López, M.E. (1) 133–143
Turró-Garriga, O., see Conde-Sala, J.L. (3) 999–1012
Ulmer, S., see Hirni, D.I. (2) 573–580
Une, K., see Waragai, M. (4) 1453–1459
Urbani, A., see Lelental, N. (1) 51–64
Uttner, I., see Küster, O.C. (2) 519–528
van Berckel, B.M.N., see Handels, R.L.H. (3) 875–885
van Domburg, P., see Handels, R.L.H. (3) 875–885
van Riet, E., see Mulder, C.K. (3) 1111–1123
van Steeg, H., see Mulder, C.K. (3) 1111–1123
Vandepitte, S., N.V.D. Noortgate, K. Putman, S. Verhaeghe, K. Faes and L. Annemans, Effectiveness of Supporting Informal Caregivers of People with Dementia: A Systematic Review of Randomized and Non-Randomized Controlled Trials (3) 929–965
Vanmechelen, E., see Roeben, B. (1) 161–169
Vanninen, R., see Koivisto, A.M. (2) 497–507
Vázquez-Cuevas, F.G., see Isla, A.G. (1) 333–343
Veeranki, S.P., see Downer, B. (1) 191–203
Vega, M., see Fernandez, A.M. (4) 1471–1478
Venketasubramanian, N., see Xu, X. (3) 1021–1028
Verbeek, M.M., see Lelental, N. (1) 51–64
Verbeek, M.M., see Müller, M. (4) 1321–1333
Vercambre, M.-N., O.I. Okereke, I. Kawachi, F. Grodstein and J.H. Kang, Self-Reported Change in Quality of Life with Retirement and Later Cognitive Decline: Prospective Data from the Nurses’ Health Study (3) 887–898
Verdile, G., see Gardener, S.L. (2) 661–672
Verdile, G., see Jayne, T. (3) 781–799
Verhaeghe, S., see Vandepitte, S. (3) 929–965
Verhey, F.R.J., see Handels, R.L.H. (3) 875–885
Verret, L., see Bensaïdane, M.R. (4) 1251–1262
Versleijen, A.A.M., see Müller, M. (4) 1321–1333
Viana, S.D., see Rego, Â. (4) 1189–1202
Vidal, J.-S., O. Hanon, B. Funalot, N. Brunel, C. Viollet, A.-S. Rigaud, M.-L. Seux, Y. le-Bouc, J. Epelbaum and E. Duron, Low Serum Insulin-Like Growth Factor-I Predicts Cognitive Decline in Alzheimer’s Disease (2) 641–649
Viñas-Diez, V., see Conde-Sala, J.L. (3) 999–1012
Vincelette, J., see Spilman, P.R. (1) 223–242
Viollet, C., see Vidal, J.-S. (2) 641–649
Visser, P.-J., see Handels, R.L.H. (3) 875–885
Viswanathan, A., see Xiong, L. (1) 171–178
Vitorica, J., see Fernandez, A.M. (4) 1471–1478
Vollert, C., see Tanifum, E.A. (2) 731–745
von Arnim, C.A.F., see Küster, O.C. (2) 519–528
Vos, S.J.B., see Handels, R.L.H. (3) 875–885
Waldemar, G., see Schütt, T. (2) 433–449
Wall, M.M., see Zahodne, L.B. (3) 1013–1020
Wan, Y., see Tan, C.-C. (1) 43–50
Wan, Y., see Wang, H.-F. (1) 179–190
Wan, Y., see Zhao, Q.-F. (2) 693–703
Wang, H.-F., see Zhao, Q.-F. (2) 693–703
Wang, H.-F., Y. Wan, X.-K. Hao, L. Cao, X.-C. Zhu, T. Jiang, M.-S. Tan, L. Tan, D.-Q. Zhang, L. Tan, J.-T. Yu and Alzheimer’s Disease Neuroimaging Initiative, Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer’s Disease Risk by Altering Neuronal Degeneration (1) 179–190
Wang, J., see Iyappan, A. (4) 1343–1360
Wang, J., see Liu, C.-H. (3) 1081–1088
Wang, K., see Zeng, L. (3) 813–823
Wang, L., see Zeng, L. (3) 813–823
Wang, M., see Meng, X. (3) 1135–1150
Wang, M.J., S. Yi, J.-y. Han, S.Y. Park, J.-W. Jang, I.K. Chun, V.V. Giau, E. Bagyinszky, K.T. Lim, S.M. Kang, S.S.A. An, Y.H. Park, Y.C. Youn and S.Y. Kim, Analysis of Cerebrospinal Fluid and [11C]PIB PET Biomarkers for Alzheimer’s Disease with Updated Protocols (4) 1403–1413
Wang, N., L. Zeng, X. Zeng, J. Liu, W. Liang and Q. Wang, A Population Perspective on Ethical Compliance with Drug Trial Standards of Practice (3) 829–830
Wang, N., see Hu, Q. (2) 747–756
Wang, N., see Zeng, L. (3) 813–823
Wang, Q., see Wang, N. (3) 829–830
Wang, Q., see Xing, Y. (3) 1029–1035
Wang, Q., see Zeng, L. (3) 813–823
Wang, Q.-H., see Liu, C.-H. (3) 1081–1088
Wang, W., L. Lu, Q.-q. Wu and J.-p. Jia, Brain Amyloid-β Plays an Initiating Role in the Pathophysiological Process of the PS1V97L-Tg Mouse Model of Alzheimer’s Disease (3) 1089–1099
Wang, X., see Liu, C.-H. (3) 1081–1088
Wang, X., see Yang, C. (2) 391–402
Wang, Y.-J. see Liu, C.-H. (3) 1081–1088
Wang, Z.-X., see Tan, C.-C. (1) 43–50
Waragai, M., A. Adame, I. Trinh, K. Sekiyama, Y. Takamatsu, K. Une, E. Masliah and M. Hashimoto, Possible Involvement of Adiponectin, the Anti-Diabetes Molecule, in the Pathogenesis of Alzheimer’s Disease (4) 1453–1459
Waragai, M., see Sekiyama, K. (3) 831–841
Ward, J., see Connors, M.H. (3) 967–974
Ward, M., see Westwood, S. (2) 561–572
Warner, D.S., see Berger, M. (4) 1299–1310
Weinborn, M., see Gardener, S.L. (2) 661–672
Wengreen, H., see Sanders, C. (1) 33–42
Werhane, M., see Bangen, K.J. (3) 849–861
Westdijk, J., see Mulder, C.K. (3) 1111–1123
Westwood, S., E. Leoni, A. Hye, S. Lynham, M.R. Khondoker, N.J. Ashton, S.J. Kiddle, A.L. Baird, R. Sainz-Fuertes, R. Leung, J. Graf, C.T. Hehir, D. Baker, C. Cereda, C. Bazenet, M. Ward, M. Thambisetty and S. Lovestone, Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly (2) 561–572
Whisner, C.M., see Miller, B.J. (3) 843–847
Williams, R.S.B., see Otto, G.P. (4) 1177–1187
Wiltfang, J., see Lelental, N. (1) 51–64
Winblad, B., see Lelental, N. (1) 51–64
Winblad, B., see Piazza, F. (2) 417–420
Wolfs, C.A.G., see Handels, R.L.H. (3) 875–885
Wong, R., see Downer, B. (1) 191–203
Wong, T.Y., see Xu, X. (3) 1021–1028
Woodward, M., see Connors, M.H. (3) 967–974
Wu, Q.-q., see Wang, W. (3) 1089–1099
Wucherer, D., see Eichler, T. (2) 619–629
Wucherer, D., see Thyrian, J.R. (2) 609–617
Wurster, I., see Roeben, B. (1) 161–169
Xavier, A.C., see Pliássova, A. (4) 1209–1214
Xiang, Y., see Liu, C.-H. (3) 1081–1088
Xie, H., see Zeng, L. (3) 813–823
Xing, Y., Y. Tang, L. Zhao, Q. Wang, W. Qin, J.-L. Zhang and J. Jia, Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer’s Disease (3) 1029–1035
Xiong, L., S. Davidsdottir, Y.D. Reijmer, A. Shoamanesh, D. Roongpiboonsopit, S. Thanprasertsuk, S. Martinez-Ramirez, A. Charidimou, A.M. Ayres, P. Fotiadis, E. Gurol, D.L. Blacker, S.M. Greenberg and A. Viswanathan, Cognitive Profile and its Association with Neuroimaging Markers of Non-Demented Cerebral Amyloid Angiopathy Patients in a Stroke Unit (1) 171–178
Xu, J., see Heffernan, M. (2) 529–538
Xu, K., see Zhan, Y. (3) 913–927
Xu, W., see Pimouguet, C. (1) 213–222
Xu, W., see Zeng, L. (3) 813–823
Xu, X., S. Hilal, S.L. Collinson, Q.L. Chan, E.J. Yi Chong, M.K. Ikram, N. Venketasubramanian, C.-Y. Cheng, T.Y. Wong and C.L.-H. Chen, Validation of the Total Cerebrovascular Disease Burden Scale in a Community Sample (3) 1021–1028
Yamamoto, Y., see Hattori, Y. (3) 1037–1045
Yamashita, T., see Shang, J. (1) 113–126
Yamashita, T., see Takemoto, M. (1) 205–211
Yamashita, T., see Zhai, Y. (4) 1311–1319
Yang, C., X. Huang, X. Huang, H. Mai, J. Li, T. Jiang, X. Wang and T. Lü, Aquaporin-4 and Alzheimer’s Disease (2) 391–402
Yang, D.W., see Yoon, B. (1) 91–99
Yang, H., see Eyre, H.A. (2) 673–684
Yang, N., see Zhu, D. (2) 483–495
Yao, X.-Q., see Liu, C.-H. (3) 1081–1088
Ye, B.S., Y. Lee, K. Kwak, Y.-H. Park, J.H. Ham, J.J. Lee, N.-Y. Shin, J.-M. Lee, Y.H. Sohn and P.H. Lee, Posterior Ventricular Enlargement to Differentiate Dementia with Lewy Bodies from Alzheimer’s Disease (4) 1237–1243
Ye, Q., F. Bai and Z. Zhang, Shared Genetic Risk Factors for Late-Life Depression and Alzheimer’s Disease (1) 1–15
Yen, F.T., see Colin, J. (3) 975–987
Yi Chong, E.J., see Xu, X. (3) 1021–1028
Yi, S., see Wang, M.J. (4) 1403–1413
Yin, S., see Zhai, Y. (2) 631–639
Yoon, B., D.W. Yang, Y.J. Hong, S.H. Choi, S.A. Park, H.K. Park, Y.D. Kim and Y.S. Shim, Differences in Depressive Patterns According to Disease Severity in Early-Onset Alzheimer’s Disease (1) 91–99
Youn, Y.C., see Wang, M.J. (4) 1403–1413
Younesi, E., see Iyappan, A. (4) 1343–1360
Yu, J.-T., see Tan, C.-C. (1) 43–50
Yu, J.-T., see Tang, S.-S. (4) 1157–1175
Yu, J.-T., see Wang, H.-F. (1) 179–190
Yu, J.-T., see Zhao, Q.-F. (2) 693–703
Yus, M., see López, M.E. (1) 133–143
Zahodne, L.B., N. Schupf, A.M. Brickman, R. Mayeux, M.M. Wall, Y. Stern and J.J. Manly, Dementia Risk and Protective Factors Differ in the Context of Memory Trajectory Groups (3) 1013–1020
Zanette, M., see Beach, T.G. (3) 863–873
Zeng, L., see Wang, N. (3) 829–830
Zeng, L., W. Liang, J. Pan, Y. Cao, J. Liu, Q. Wang, L. Wang, Y. Zou, K. Wang, L. Kong, H. Xie, W. Xu, W. Li, W. Zhao, S. Mi, Y. Chen, S. Cheng, X. Li, Q. Cao, X. Zeng and N. Wang, Do Chinese Researchers Conduct Ethical Research and Use Ethics Committee Review in Clinical Trials of Anti-Dementia Drugs? An Analysis of Bio-medical Publications Originating from China (3) 813–823
Zeng, X., see Wang, N. (3) 829–830
Zeng, X., see Zeng, L. (3) 813–823
Zetterberg, H., see Hoscheidt, S.M. (4) 1373–1383
Zetterberg, H., see Jefferson, A.L. (2) 539–559
Zetterberg, H., see Lelental, N. (1) 51–64
Zhai, Y., S. Yin and D. Zhang, Association between Antipsychotic Drugs and Mortality in Older Persons with Alzheimer’s Disease: A Systematic Review and Meta-Analysis (2) 631–639
Zhai, Y., see Shang, J. (1) 113–126
Zhai, Y., T. Yamashita, Y. Nakano, Z. Sun, R. Morihara, Y. Fukui, Y. Ohta, N. Hishikawa and K. Abe, Disruption of White Matter Integrity by Chronic Cerebral Hypoperfusion in Alzheimer’s Disease Mouse Model (4) 1311–1319
Zhan, Y., J. Ma, A.F. Alexander-Bloch, K. Xu, Y. Cui, Q. Feng, T. Jiang and Y. Liu for the Alzheimer’s Disease Neuroimaging Initiative, Longitudinal Study of Impaired Intra- and Inter-Network Brain Connectivity in Subjects at High Risk for Alzheimer’s Disease (3) 913–927
Zhang, A., see Zhang, X. (1) 101–111
Zhang, D., see Zhai, Y. (2) 631–639
Zhang, D.-Q., see Wang, H.-F. (1) 179–190
Zhang, D.-Q., see Zhao, Q.-F. (2) 693–703
Zhang, J., see Spilman, P.R. (1) 223–242
Zhang, J.-L., see Xing, Y. (3) 1029–1035
Zhang, M., see Liu, C.-H. (3) 1081–1088
Zhang, T., see Liu, C.-H. (3) 1081–1088
Zhang, W., see Tan, C.-C. (1) 43–50
Zhang, X., X. Cai, X. Shi, Z. Zheng, A. Zhang, J. Guo and Y. Fang, Chronic Obstructive Pulmonary Disease as a Risk Factor for Cognitive Dysfunction: A Meta-Analysis of Current Studies (1) 101–111
Zhang, Z., see Ye, Q., (1) 1–15
Zhao, J., see Huang, H.-C. (3) 899–911
Zhao, J., see Meng, X. (3) 1135–1150
Zhao, J.-Y., see Huang, H.-C. (3) 899–911
Zhao, L., see Xing, Y. (3) 1029–1035
Zhao, Q.-F., Y. Wan, H.-F. Wang, F.-R. Sun, X.-K. Hao, M.-S. Tan, C.-C. Tan, D.-Q. Zhang, L. Tan, J.-T. Yu and Alzheimer’s Disease Neuroimaging Initiative, ABCA7 Genotypes Confer Alz-heimer’s Disease Risk by Modulating -Amyloid-β Pathology (2) 693–703
Zhao, W., see Zeng, L. (3) 813–823
Zheng, B.-W., see Huang, H.-C. (3) 899–911
Zheng, J., see Zhu, D. (2) 483–495
Zheng, Z., see Zhang, X. (1) 101–111
Zhou, H.-D., see Liu, C.-H. (3) 1081–1088
Zhu, C., see Liu, C.-H. (3) 1081–1088
Zhu, D., N. Yang, Y.-Y. Liu, J. Zheng, C. Ji and P.-P. Zuo, M2 Macrophage Transplantation Ameliorates Cognitive Dysfunction in Amyloid-β-Treated Rats Through Regulation of Microglial Polarization (2) 483–495
Zhu, X.-C., see Wang, H.-F. (1) 179–190
Zilka, N., see Lelental, N. (1) 51–64
Zonderman, A.B., see Beydoun, M.A. (4) 1415–1430
Zou, Y., see Zeng, L. (3) 813–823
Zuffi, M., see Clarelli, F. (4) 1203–1208
Zuo, P.-P., see Zhu, D. (2) 483–495
Zurrón, M., see Ramos-Goicoa, M. (4) 1487–1501
